Abstract:Neurodegenerative diseases are becoming prevalent as the population ages. Geniposide could inhibit oxidative stress, reduce apoptosis, protect neuron, and has been used for therapy of the neurodegenerative diseases. The bioavailability of geniposide by nasal route is greater than that by oral administration. However, mucociliary clearance is a rate-limiting factor for nasal route administration. The objective of this study was to develop and evaluate a mucoadhesive, thermoreversible in situ nasal gel of geniposide. The poloxamers (P407, P188) and the hydroxypropyl methylcellulose were used as thermoreversible and mucoadhesive polymers, respectively. Borneol was used as a permeation enhancer. The hydrogel was prepared with the cold method and optimized by the response surface methodology-central composite design. Gelation temperature, pH, clarity, gel strength, mucoadhesive strength, in vitro and ex vivo release kinetics of formulations were evaluated. The optimized amounts of poloxamer407 (P407), poloxamer188 (P188) and hydroxypropyl methylcellulose were determined to be 19.4-20.5%, 1.1-4.0% and 0.3-0.6% respectively. The second-order polynomial equation in terms of actual factors indicated a satisfactory correlation between the independent variables and the response (R2 = 0.9760). An ANOVA of the empirical second-order polynomial model indicated the model was significant (P<0.01). P407, P188, P407×P188, P4072 and P1882 were significant model terms. The effects of P407 on gelation temperature were greater than those of other independent variables. The pH values of all the formulations were found to be within 6.3-6.5 which was in the nasal physiological pH range 4.5-6.5. The drug content, gel strength, mucoadhesive strength of the optimized formulations were 97-101%, 25-50 sec and 4000-6000 dyn/cm2 respectively. The in vitro release kinetics of cumulative release of geniposide was fitted to the zero-order model. The ex vivo cumulative release kinetics of geniposide was fitted to the Weibull model. This study concludes that the release of geniposide is controlled by gel corrosion, and that the permeation of geniposide is time-dependent. The more residence time, mucoadhesive, thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases is of compliance and potential application.

Preparation of Mpeg2000-Pla-modified Xingnaojing Microemulsion and Evaluation in Mucosal Irritation.

Study on pharmacokinetics of geniposide in mice administrated by Xingnaojing microemulsion and mPEG2000-PLA modified Xingnaojing microemulsion

Preparation, Characterization and Nasal Delivery of Alpha-Cobrotoxin-Loaded Poly(Lactide-Co-Glycolide)/Polyanhydride Microspheres

Comparative Study on Rat in Situ Nasal Absorption of Geniposide of Xingnaojing Nasal Drop and Xingnaojing Microemulsion

Preparation and in vitro characterization of thermosensitive and mucoadhesive hydrogels for nasal delivery of phenylephrine hydrochloride

Chitosan Hydrogel Doped with PEG-PLA Nanoparticles for the Local Delivery of Mirna-146A to Treat Allergic Rhinitis

The Brain Targeting Efficiency Following Nasally Applied Mpeg-Pla Nanoparticles In Rats

[Preparation of Cangyi nanoemulsion in situ gel and drug release mechanism of nasal mucosa in vitro]

Effects of surface hydrophilic properties of PEG-based mucus-penetrating nanostructured lipid carriers on oral drug delivery

Optimization for formulation of Zhi Xiong San thermo-sensitive gel by central composite design-response surface method and study on characterization of its nasal mucosal permeability

An in situ gel system for nasal delivery of menthol: preparation and safety evaluation

A mucoadhesive, thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases

Mucus adhesion vs. mucus penetration? Screening nanomaterials for nasal inhalation by MD simulation

Modulating Intestinal Mucus Barrier for Nanoparticles Penetration by Surfactants

Mitigating Intubation Stress, Mucosa Injury, and Inflammatory Response in Nasogastric Tube Intubation Via Suppression of the NF-κB Signaling Pathway by Engineering a Hydration Lubrication Coating.

Preparation and in Vitro Release of Mpeg-Pla Microspheres of Panax Notoginseng Saponins

Immunosafety and chronic toxicity evaluation of monomethoxypoly(ethylene glycol)-b-poly(lactic acid) polymer micelles for paclitaxel delivery

PLGA Nanoparticle Platform for Trans-Ocular Barrier to Enhance Drug Delivery: A Comparative Study Based on the Application of Oligosaccharides in the Outer Membrane of Carriers

Preparation and in Vitro Release of Buccal Tablets of Naringenin-Loaded MPEG-PCL Nanoparticles

Evaluation of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer nanomicelle for trigeminal ganglion neurons delivering with intranasal administration

Development and Characterization of n-Propyl Gallate Encapsulated Solid Lipid Nanoparticles-Loaded Hydrogel for Intranasal Delivery